Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions

Blood

Volumn 89, Issue 2, 1997, Pages 630-643

  Zhou, Ping ^a   Qian, Liping ^a   Kozopas, Karen M ^a   Craig, Ruth W ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM IONOPHORE; COMPLEMENTARY DNA; DEXAMETHASONE; ETOPOSIDE; GENE PRODUCT;

ANIMAL CELL; ARTICLE; CELL CLONE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ELECTROPORATION; GENE EXPRESSION; HEMATOPOIETIC CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMYELOCYTE;

EID: 0031034078     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.2.630     Document Type: Article

References (68)

1. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka L, Mao X, Nunez G, Thompson CB: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597, 1993
2. Cleary ML, Smith SD, Sklar J: Cloning and structural analysis of cDNA for bel-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14; 18) translocation. Cell 47:19, 1986
3. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW: MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL-2. Proc Natl Acad Sci USA 90:3516, 1993
4. Tsujimoto Y, Croce CM: Analysis of the structure, transcripts, and protein products of bcl, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83:5214, 1986
5. Yang T, Kozopas KM, Craig RW: The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2. J Cell Biol 128:1173, 1995
6. Craig RW, Frankfurt OS, Sakagami H, Takeda K, Bloch A: Macromolecular and cell cycle effects of different classes of agents inducing the maturation of human myeloblastic leukemia (ML-1) cells. Cancer Res 44:2421, 1995
7. Krajewski S, Bodrug S, Krajewska M, Shabaik A, Gascoyne R, Berean K, Reed JC: Immunohistochemical analysis of Mcl-1 protein in human tissues: Differential regulation of Mcl-c and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol 146:1309, 1995
8. Hockenbery D, Nunez G, Minniman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334, 1990
9. Vaux DL, Cory S, Adams JM: Bcl-2 gene promotes hemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440, 1988
10. Garcia I, Martinou I, Tsujimoto Y, Martinou J: Prevention of programmed cell death of sympathetic neurons by the bcl-2 protooncogene. Science 258:302, 1992
11. Kamesaki S, Kamesaki H, Jorgensen TJ, Tanizawa A, Pommier Y, Cossman J: bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair. Cancer Res 53:4251, 1993
12. Manome Y, Weichselbaum RR, Kufe DW, Fine HA: Effect of Bcl-2 on ionizing radiation and 1-beta-D-arabinofuranosylcytosine-induced internuclcosomal DNA fragmentation and cell survival in human myeloid leukemia cells. Oncol Res 5:139, 1993
13. May WS, Tyler PG, Ito T, Armstrong DK, Qatsha KA, Davidson NE: Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 alpha in association with suppression of apoptosis. J Biol Chem 269:26865, 1994
14. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP, Korsmeyer SJ: bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57:79, 1992
15. Miyashita T, Reed JC: Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151, 1993
16. Sentman C, Shutter J, Hockenbery D, Kanagawa D, Korsmeyer SJ: bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879, 1991
17. Strasser A, Harris A, Cory S: bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889, 1991
18. Walton MI, Whysong D, O'Connor PM, Hockenbery D, Korsmeyer SJ, Kohn KW: Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res 53:1853, 1993
19. Yin X-M, Oltvai Z, Korsmeyer SJ: BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with bax. Nature 369:321, 1994
20. Borner C: Diminished cell proliferation associated with the death-protective activity of bcl-2. J Biol Chem 271:12695, 1996
21. Hengartner MO, Horvitz HR: C. clegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76:665, 1994
22. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A: Epstein-Barr virus-encoded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci USA 90:8479, 1993
23. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programed cell death. Cell 74:609, 1993
24. Yin X-M, Oltvai Z, Korsmeyer SJ: BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with bax. Nature 369:321, 1994
25. Reynolds JE, Yang T, Qian L, Jenkinson JD, Zhou P, Eastman A, Craig RW: Mcl-1, a member ot the bcl-2 family, delays apoptosis induced by c-myc overexpression in Chinese hamster ovary cells. Cancer Res 54:6348, 1994
26. Sato T, Hanada M, Bodrug S, Irie S, Iwama N, Boise LH, Thompson CB, Golemis E, Fong L, Wang H-G, Reed JC: Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 91:9238, 1994
27. Bodrug SE, Aime-Sempe C, Sata T, Krajewski S, Hanada M, Reed JC: Biochemical and functional comparisons of Mel-1 and Bcl-2 proteins: Evidence for a novel mechanism of regulating bcl-2 family protein function. Cell Death Differ 2:173, 1995
28. Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M, Reed JC: Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol 145:515, 1994
29. Yang T, Buchan HL, Townsend KJ, Craig RW: MCL-1, a member of the BCL-2 family, is induced rapidly in response to signals for cell differentiation or death, but not to signals for cell proliferation. J Cell Physiol 166:523, 1996
30. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ: Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602, 1990
31. Barry MA, Reynolds JE, Eastman A: Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification. Cancer Res 53:2349, 1993
32. Caron-Leslie LM, Evans RB, Cidlowski JA: Bcl-2 inhibits glucocorticoid-induced apoptosis but only partially blocks calcium ionophore or cycloheximide regulated apoptosis in S49 cells. FASEB J 8:639, 1994
33. Martin SJ, Cotter TG: Ultraviolet B irradiation of human leukemia HL-60 cells in vitro induces apoptosis. Int J Radiat Biol 59:1001, 1991
34. Walker PR, Smith C, Youdale T, Leblanc J, Whitfield JF, Sikorska M: Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res 51:1078, 1991
35. Lee JC, Hapel AJ, Ihle JN: Constitutive production of a unique lymphokine (IL-3) by WEHI-3 cell line. J Immunol 128:2393, 1982
36. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B: Suppression of human colorectal carcinoma cell growth by wildtype p53. Science 249:912, 1990
37. Harlow E, Lane D: Antibodies, A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1988
38. Duke R, Cohen JJ: Morphological and biochemical assays of apoptosis, in Coligan JE, Kruisbeek AM, Margulies DH, Shevack EM, Strober W (eds): Current Protocols in Immunology. New York, NY, John Wiley and Sons, 1991, p 3.17.1
39. Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 68:251, 1980
40. Arends MJ, Wyllie AH: Apoptosis: Mechanisms and roles in pathology. Int Rev Exp Pathol 32:223, 1991
41. Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB, Korsmeyer SJ: Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Nail Acad Sci USA 92:7834, 1995
42. Morana SJ, Wolf CM, Li J, Reynolds JE, Brown MK, Eastman A: The involvement of protein phosphatases in the activation of ICE/CED-3 protease, intracellular acidification, DNA digestion, and apoptosis. J Biol Chem 271:18263, 1996
43. Kaufmann SH: Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etopside, camptothecin, and other cytotoxic anticancer drugs: A cautionary note. Cancer Res 49:5870, 1989
44. Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DR: Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76, 1993
45. Bartner CD, Olderburg NBE, Cidlowski JA: The role of DNA fragmentation in apoptosis. Trends Cell Biol 5:21, 1995
46. Beere HM, Chresta CM, Alejo-Herberg A, Skladanowski A, Dive C, Larsen AK, Hickman J: Investigation of the mechanism of higher order chromatin fragmentation observed in drug-induced apoptosis. Mol Pharmacol 47:986, 1995
47. Ascaso R, Marvel J, Collins MKL, Lopez-Rivas A: Interleukin-3 and Bcl-2 cooperatively inhibit etoposide-induced apoptosis in a murine pre-B cell line. Eur J Immunol 24:537, 1994
48. Fukunaga-Johnson N, Ryan JJ, Wicha M, Nunez G, Clarke MF: Bcl-2 protects murine erythroleukemia cells from p53-dependent and -independent radiation-induced cell death. Carcinogenesis 16:1761, 1995
49. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849, 1993
50. Martin SJ, Cotter TG: Disruption of microtubules induces an endogenous suicide pathway in human leukaemia HL-60 cells. Cell Tissue Kinet 23:545, 1990
51. Hardin J, MacLeod S, Grigorieva I, Chang R, Barlogie B, Xiao H, Epstein J: Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood 84:3063, 1994
52. Otani H, Erdos M, Leonard WJ: Tyrosine kinase(s) regulate apoptosis and bcl-2 expression in a growth factor-dependent cell line. J Biol Chem 268:22733, 1993
53. Rinaudo MS, Su K, Falk LA, Haldar S, Mufson RA: Human interleukin-3 receptor modulates bcl-2 mRNA and protein levels through protein kinase C in TF-1 cells. Blood 86:80, 1995
54. Dole MG, Jasty R, Cooper MJ, Thompson CB, Nunez G, Castle VP: Bcl-x is expressed in neuroblasloma cells and modulates chemotherapy-induced apoptosis. Cancer Res 55:2576, 1995
55. Hanada M, Krajewski S, Tanaka S, Cazals-Hatem D, Spengler BA, Ross RA, Biedler JL, Reed JC: Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Cancer Res 53:4978, 1993
56. Algate PA, McCubrey JA: Automne transformation of hemopeietic cells resulting from cytokine message stabilization after intracisternal A particle transposition. Oncogene 8:1221, 1993
57. Cleveland JL, Troppmair J, Packham G, Askew DS, Lloyd P, Gonzalez-Garcia M, Nunez G, Ihle JN, Rapp UR: v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells. Oncogene 9:2217, 1994
58. Isfort RJ: Frequency and mechanisms of factor independence in IL-3-dependent cell lines. Somatic Cell Mol Genet 16:109, 1990
59. McCubrey JA, Smith SR, Algate PA, DeVente JE, White MK, Steelman LS: Retroviral infection can abrogate the factor-dependency of hematopoietic cells by autocrine and non-autocrine mechanisms depending on the presence of a functional viral oncogene. Oncogene 8:2905, 1992
60. Rasko JEJ, Metcalf D, Gough N, Begley CG: The cytokine receptor repertoire specifies autocrine growth factor production in factor-dependent cells. Exp Hematol 23:453, 1995
61. Kinoshita T, Yokota T, Arai K, Miyajima A: Regulation of bcl-2 expression by oncogenic Ras protein in hematopoietic cells. Oncogene 10:2207, 1995
62. Kinoshita T, Yokota T, Arai K, Miyuajima A: Suppression of apoptotic death in hemalopoietic cells by signaling through the IL-3/GM-CSF receptors. EMBOJ 14:266, 1995
63. Uhlmann EJ, D'Sa-Eipper C, Subrumaniun T, Wagner AJ, Hay N, Chinnadurai G: Deletion of a nonconserved region of bcl-2 confers a novel gain of function: Suppression of apoptosis with concomitant cell proliferation. Cancer Res 56:2506, 1996
64. Reynolds JE, Li J, Craig RW, Eastman A: BCL-2 and MCL-1 expression in Chinese hamster ovary cells inhibits intracellular acidification and apoptosis induced by staurosporin. Exp Cell Res 225:430, 1996
65. Zhou P, Qian L, Levy NL, Noll WW, Binder M, Craig RW: The mcl-1 gene expressed in transgenic mice exhibits enhancing effects on cell survival, in Horvitz HR, Korsmeyer S, White E (eds): Abstracts of Papers Presented at the 1995 Meeting on Programmed Cell Death. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1995, p 69
66. Fairbairn LJ, Cowling GJ, Reipert BM, Dexter TM: Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 74:823, 1993
67. + stage during positive selection and promotes thymocyte differentiation at several control points. Immunity 1:197, 1994
68. Hartley SB,Cooke MP, Fulcher DA, Harris AW, Cory S, Basten A, Goodnow CC: Elimination of self-reactive B lymphocytes proceeds in two stages: Arrested development and cell death. Cell 72:325, 1993